Oppenheimer Initiates Coverage On Astrana Health with Outperform Rating, Announces Price Target of $53

Benzinga · 1d ago
Oppenheimer analyst Michael Wiederhorn initiates coverage on Astrana Health (NASDAQ:ASTH) with a Outperform rating and announces Price Target of $53.